A Study of U-500 Insulin (LY041001) in Participants With Type 2 Diabetes
B5K-EW-IBHG - ClinicalTrials.gov - NCT02588950
The purpose of this study is to measure how much of the study drug gets into the blood stream and how long it takes the body to get rid of it.
Trial Summary
Age Range
18 - 74 yearsConditions the trial is for
What the trial is testing?
Could I receive a Placebo?
NoEnrollment Goal
11Trial Dates
Jan 12, 2016 - May 25, 2017How long will I be in the trial?
Your participation could last from 7 to 14 weeks and include 5 visits to the study center.Trial Phase
ILilly Trial Alerts
Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.
You will complete the questionnaire on another website.YesNo